We serve Chemical Name:2-AMINO-6-METHYL-3-PYRIDINECARBOXYLIC ACID CAS:846021-26-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-AMINO-6-METHYL-3-PYRIDINECARBOXYLIC ACID
CAS.NO:846021-26-9
Synonyms:2-AMINO-6-METHYL-3-PYRIDINECARBOXYLIC ACID;2-amino-6-methylnicotinic acid;2-Amino-6-methyl-nicotinsaeure
Molecular Formula:C7H8N2O2
Molecular Weight:152.15100
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:339.9ºC at 760 mmHg
Density:1.337g/cm3
Index of Refraction:1.627
PSA:76.21000
Exact Mass:152.05900
LogP:1.25160
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-AMINO-6-METHYL-3-PYRIDINECARBOXYLIC ACID chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Amino-6-methyl-nicotinsaeure physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Amino-6-methyl-nicotinsaeure Use and application,2-Amino-6-methyl-nicotinsaeure technical grade,usp/ep/jp grade.
Related News: Without disclosing or confirming the number of vaccine doses, the FDA said in a news release that it had authorized two batches of the vaccine for use, that several other batches were not suitable for use and that others were being evaluated. 2-AMINO-6-METHYL-3-PYRIDINECARBOXYLIC ACID manufacturer The FDA has granted so-called accelerated approval in more than 250 instances since 1992, mainly for rare diseases or small patient populations that have had no effective treatments available to them. In these cases, the agency requires that drugmakers conduct additional clinical trials to prove their therapy works, or face withdrawal from the market. 2-AMINO-6-METHYL-3-PYRIDINECARBOXYLIC ACID supplier The FDA has granted so-called accelerated approval in more than 250 instances since 1992, mainly for rare diseases or small patient populations that have had no effective treatments available to them. In these cases, the agency requires that drugmakers conduct additional clinical trials to prove their therapy works, or face withdrawal from the market. 2-AMINO-6-METHYL-3-PYRIDINECARBOXYLIC ACID vendor Without disclosing or confirming the number of vaccine doses, the FDA said in a news release that it had authorized two batches of the vaccine for use, that several other batches were not suitable for use and that others were being evaluated. 2-AMINO-6-METHYL-3-PYRIDINECARBOXYLIC ACID factory With the structural upgrade of the pharmaceutical industry in developed countries, the transfer of related industrial chains has taken place globally, and it has also had a profound impact on Chinese pharmaceutical companies. near
